Cardiovascular Disease from Copper Deficiency—A History
نویسندگان
چکیده
منابع مشابه
Family history of cardiovascular disease.
Evidence Where possible, odds ratios (ORs) have been converted to relative risks (RRs). • A total of 2302 male and female Framingham offspring study participants with parental history of premature CVD (father < 55 years, mother < 65 years) were analyzed for CVD risk.1 After 8 years of followup, CVD increased 75% with paternal and about 60% with maternal history of premature CVD. • Using the sam...
متن کاملCell Therapy in Cardiovascular Disease
Recently, cell therapy has sparked a revolution in ischemic heart disease that will in the future help clinicians to cure patients. Earlier investigations in animal models and clinical trials have suggested that positive paracrine effects such as neoangiogenesis and anti-apoptotic can improve myocardial function. In this regard the Royan cell therapy center designed a few trials in collaborat...
متن کاملSerum copper and zinc concentrations in serum from patients with cancer and cardiovascular disease.
A single cross-sectional study for serum copper and zinc levels was evaluated in 20 patients with cancer (respiratory, digestive, haematological, gynaecological) and 21 patients with cardiopathy (acute myocardial infarction and ischemic cardiomyopathy). A control group of 84 healthy subjects was selected. The mean serum zinc levels in patients with gynaecological cancer and ischemic cardiomyopa...
متن کاملMedicine and history Platelets , aspirin , and cardiovascular disease
Aspirin was first synthesised 100 years ago and its preparation and marketing is generally reckoned to have been the foundation of the pharmaceutical industry. For most of the time since then it has been used for the reliefofpain and fever. The modern phase of aspirin use commenced with the reporting in 1974 of a randomised controlled trial in the secondary prevention of death by low-dose aspir...
متن کاملThe role of microRNAs in cardiovascular disease
Cardiovascular disease has become the main factor of death and birth defects in the world. There are some therapeutic structures and drugs for curative and palliative therapy of the disease, but to the aim of accessing reliable therapy or to postpone onset of disease, especially for individuals with heritable coronary artery disease in their pedigree Genetic engineering technologies are making...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Nutrition
سال: 2000
ISSN: 0022-3166,1541-6100
DOI: 10.1093/jn/130.2.489s